Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for ruxolitinib
Apotex has told investors and the press that, once Health Canada clears the product, the generic form of ruxolitinib should hit the Canadian market in the second quarter of 2024. The company has not yet set an exact launch date— it will be confirmed when the drug receives approval, but the “expected launch” is mid‑2024.
Other Questions About Ruxolitinib :